By identifying gene products whose knockdown is associated with phenotypic changes, large-scale RNA-mediated interference screens have demonstrated previously unknown components of biological pathways. This commentary provides general guidelines for using such screens to answer questions of immunological interest.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Dissecting phenotypic responses of the druggable targetome in cancers
Scientific Reports Open Access 29 August 2019
-
A cross-species whole genome siRNA screen in suspension-cultured Chinese hamster ovary cells identifies novel engineering targets
Scientific Reports Open Access 18 June 2019
-
RNAi screen reveals synthetic lethality between cyclin G-associated kinase and FBXW7 by inducing aberrant mitoses
British Journal of Cancer Open Access 22 August 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout



References
Echeverri, C.J. & Perrimon, N. Nat. Rev. Genet. 7, 373–384 (2006).
Perrimon, N. & Mathey-Prevot, B. Genetics 175, 7–16 (2007).
Moffat, J. & Sabatini, D.M. Nat. Rev. Mol. Cell Biol. 7, 177–187 (2006).
Brummelkamp, T.R., Nijman, S.M., Dirac, A.M. & Bernards, R. Nature 424, 797–801 (2003).
Oberdoerffer, S. et al. Science 321, 686–691 (2008).
Wu, Z. et al. Immunity 29, 839–841 (2008).
Feske, S. et al. Nature 441, 179–185 (2006).
Vig, M. et al. Science 312, 1220–1223 (2006).
Zhang, S.L. et al. Proc. Natl. Acad. Sci. USA 103, 9357–9362 (2006).
Gwack, Y. et al. Nature 441, 646–650 (2006).
Chen, Z., Stockton, J., Mathis, D. & Benoist, C. Proc. Natl. Acad. Sci. USA 103, 16400–16405 (2006).
Hannon, G.J. & Rossi, J.J. Nature 431, 371–378 (2004).
Sledz, C.A. & Williams, B.R. Biochem. Soc. Trans. 32, 952–956 (2004).
Kittler, R. et al. Nature 432, 1036–1040 (2004).
Liou, J. et al. Curr. Biol. 15, 1235–1241 (2005).
Elbashir, S.M., Lendeckel, W. & Tuschl, T. Genes Dev. 15, 188–200 (2001).
Bramsen, J.B., et al. Nucleic Acids Res. 10, 2867–2881 (2009).
McManus, M.T. et al. J. Immunol. 169, 5754–5760 (2002).
Laderach, D., Compagno, D., Danos, O., Vainchenker, W. & Galy, A. J. Immunol. 171, 1750–1757 (2003).
Brummelkamp, T.R., Bernards, R. & Agami, R. Science 296, 550–553 (2002).
Stewart, S.A. et al. RNA 9, 493–501 (2003).
Silva, J.M. et al. Nat. Genet. 37, 1281–1288 (2005).
Yamamoto, T. et al. Blood 108, 3305–3312 (2006).
Wein, M.N., Jones, D.C. & Glimcher, L.H. Methods Mol. Biol. 455, 149–155 (2008).
Ziauddin, J. & Sabatini, D.M. Nature 411, 107–110 (2001).
Neumann, B. et al. Nat. Methods 3, 385–390 (2006).
Simpson, K.J. et al. Nat. Cell Biol. 10, 1027–1038 (2008).
Zhang, J.H., Chung, T.D. & Oldenburg, K.R. J. Biomol. Screen. 4, 67–73 (1999).
Ngo, V.N. et al. Nature 441, 106–110 (2006).
Luo, B. et al. Proc. Natl. Acad. Sci. USA 105, 20380–20385 (2008).
Schlabach, M.R. et al. Science 319, 620–624 (2008).
Echeverri, C.J. et al. Nat. Methods 3, 777–779 (2006).
Judge, A.D. et al. Nat. Biotechnol. 23, 457–462 (2005).
Brass, A.L. et al. Science 319, 921–926 (2008).
Zhou, H. et al. Cell Host Microbe 4, 495–504 (2008).
König, R. et al. Cell 135, 49–60 (2008).
Goff, S.P. Cell 135, 417–420 (2008).
Bidère, N. et al. Nature 458, 92–96 (2009).
Shaffer, A.L. et al. Nature 454, 226–231 (2008).
Kaelin, W.G. Jr. Nat. Rev. Cancer 5, 689–698 (2005).
Whitehurst, A.W. et al. Nature 446, 815–819 (2007).
Acknowledgements
Supported by the US National Institutes of Health (A.R.), the Juvenile Diabetes Research Foundation (A.R.), the Canadian Institutes for Health Research (S.S.) and the Leukemia and Lymphoma Society (S.S.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A.R. is a shareholder of and scientific advisor to CaliMedica and receives laboratory support from Glaxo-Smith-Kline.
Rights and permissions
About this article
Cite this article
Sharma, S., Rao, A. RNAi screening: tips and techniques. Nat Immunol 10, 799–804 (2009). https://doi.org/10.1038/ni0809-799
Issue Date:
DOI: https://doi.org/10.1038/ni0809-799
This article is cited by
-
The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the STING–IFN-β pathway
Nature Immunology (2021)
-
Dissecting phenotypic responses of the druggable targetome in cancers
Scientific Reports (2019)
-
A cross-species whole genome siRNA screen in suspension-cultured Chinese hamster ovary cells identifies novel engineering targets
Scientific Reports (2019)
-
Adenylate Kinase: A Ubiquitous Enzyme Correlated with Medical Conditions
The Protein Journal (2019)
-
RNAi screen reveals synthetic lethality between cyclin G-associated kinase and FBXW7 by inducing aberrant mitoses
British Journal of Cancer (2017)